Advarra Joins Leading Healthcare Companies to Announce COVID-19 Research Database
Advarra has been added to a COVID-19 Research Database, a pro bono, cross-industry collaboration.
Science 37® Partners with Advarra to Expedite Virtual Trial Research for COVID-19
Science 37, the industry leader in decentralized clinical trials, and Advarra, a leading institutional review board (IRB), have partnered to expedite approvals on COVID-19–related virtual trials.
Advarra Acquires IRBco
Advarra is pleased to announce the acquisition of IRBco, an AAHRPP-accredited central IRB that has conducted research reviews in the U.S. since 1981.
Advarra Announces Appointment of Gadi Saarony as Chief Executive Officer
Advarra announced today the appointment of Gadi Saarony as Chief Executive Officer.
Advarra Technology Keeps Research Moving During COVID-19 Pandemic At Academic Institutions
Advarra today shared progress made by customers utilizing the company’s products and services to keep research moving forward during the COVID-19 pandemic.
Holiday Meeting Schedule – Good Friday (Canada)
Due to the upcoming Good Friday holiday, some review timelines have been modified.
ACRP Acknowledges Advarra for Its Free Resources During the COVID-19 Pandemic
ACRP recognized Advarra for the organization’s leadership and free guidance during the global COVID-19 pandemic in the blog article Clinical Trial Leaders Offer Free Resources to Battle COVID-19.
Health Canada Notification on Clinical Trial Management During COVID-19 Pandemic
In response to the current COVID-19 public health emergency, Health Canada has published the notification Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors.
Free Research Compliance Resources During COVID-19 Crisis
Advarra announces the availability of free resources to support and enable the clinical research community and ongoing research during the coronavirus disease (COVID-19) crisis.
FDA Guidance on Conducting Clinical Trials During COVID-19 Pandemic
FDA has released a guidance document on conducting medical product trials during the COVID-19 pandemic. Read more:
Advarra Addresses Increase in COVID-19 Studies With Rapid Reviews in Support of Government and Industry Emergency Research
Advarra handles spike in coronavirus-related submissions, activates tech-enabled platform to support broad telework policy, and maintains normalized operations. Read more:
Impact of COVID-19 Outbreak on Ongoing Research and Protocols Under Advarra IRB Review
Advarra has policies and processes in place to keep IRB operations functioning as normal during the current coronavirus outbreak. Read more: